Estonia vs France: Incidence of tuberculosis
Incidence of tuberculosis over time
- Estonia
- France
How they compare
Estonia currently reports 8.2 per 100,000 people against 7.8 per 100,000 people in France, a difference of 0.4 per 100,000 people.
That makes Estonia's figure about 1.1 times France's.
Across all 25 years both countries report, Estonia has been ahead every year.
Estonia ranks 158th and France ranks 161st of 208 countries.
Estonia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Estonia | France | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 69.2 per 100,000 people | 10.69 per 100,000 people | 58.51 per 100,000 people | Estonia |
| 2010s | 22.5 per 100,000 people | 8.83 per 100,000 people | 13.67 per 100,000 people | Estonia |
| 2020s | 10.06 per 100,000 people | 7.72 per 100,000 people | 2.34 per 100,000 people | Estonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher incidence of tuberculosis, Estonia or France?
- Estonia, at 8.2 per 100,000 people against 7.8 per 100,000 people in France as of 2024.
- What is the difference in incidence of tuberculosis between Estonia and France?
- 0.4 per 100,000 people, with Estonia ahead.
- How many years of comparable data are there for Estonia and France?
- 25 years are reported by both, from 2000 to 2024.
- How do Estonia and France rank globally for incidence of tuberculosis?
- Estonia ranks 158th and France ranks 161st of 208 countries.
- Where does this data come from?
- Global Tuberculosis Report, World Health Organization (WHO), published as Incidence of tuberculosis (per 100,000 people). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Incidence of tuberculosis is the estimated number of new and relapse tuberculosis cases arising in a given year, expressed as the rate per 100,000 population. All forms of TB are included, including cases in people living with HIV. Estimates for all years are recalculated as new information becomes available and techniques are refined, so they may differ from those published previously.